C4 Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
C4 Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q4 2024.
  • C4 Therapeutics, Inc. Depreciation for the quarter ending December 31, 2024 was $364K, a 184% increase year-over-year.
  • C4 Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2024 was $1.47M, a 6.65% decline year-over-year.
  • C4 Therapeutics, Inc. annual Depreciation for 2024 was $1.47M, a 6.65% decline from 2023.
  • C4 Therapeutics, Inc. annual Depreciation for 2023 was $1.58M, a 5.85% decline from 2022.
  • C4 Therapeutics, Inc. annual Depreciation for 2022 was $1.68M, a 12.3% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $1.47M $364K +$236K +184% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $1.24M $365K -$82K -18.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.32M $296K -$162K -35.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.48M $448K -$97K -17.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.58M $128K -$393K -75.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $1.97M $447K +$32K +7.71% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.94M $458K +$23K +5.29% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.92M $545K +$240K +78.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $1.68M $521K +$198K +61.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.48M $415K +$85K +25.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $1.39M $435K +$47K +12.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.35M $305K -$146K -32.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.49M $323K -$42K -11.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $1.53M $330K -$90K -21.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.62M $388K -$28K -6.73% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.65M $451K +$35K +8.41% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.62M $365K Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $420K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $416K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $416K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.